Atrial Fibrillation: all 3,957 studies

Page 14 of 40. Open to participants first (933), then studies with results posted, then the rest; newest registration first within each.

• Validation Durability Adenosine Effect in Verification Pulmonary Vein IsolationCompletedNCT01590875Not applicableResults posted
• NAVISTAR® THERMOCOOL® SF Catheter: Observational StudyCompletedNCT01585961Results posted
• Recording for Potential AF Drivers and Patient Specific Atrial Anatomy & Atrial Electrogram MapsCompletedNCT01581437Not applicableResults posted
• Dabigatran Adherence Pilot Intervention for Patients With Atrial FibrillationCompletedNCT01578044Not applicableResults posted
• Atrial Fibrillation Progression TrialTerminatedNCT01570361Phase 4Results posted
• Evaluation of the Cardioblate CryoFlex Surgical Ablation System in Longstanding Persistent Atrial FibrillationTerminatedNCT01558635Not applicableResults posted
• Combined Amiodarone and Electrical Cardioversion for Postoperative Atrial Fibrillation After Cardiac SurgeryTerminatedNCT01558128Not applicableResults posted
• Dabigatran's Effect on Changes in Atrial Fibrosis in Patients With Atrial FibrillationTerminatedNCT01546883Phase 4Results posted
• Deviating the Esophagus in Atrial Fibrillation AblationTerminatedNCT01546168Not applicableResults posted
• Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversionCompletedNCT01534962Phase 2Results posted
• Medtronic Reveal XT StudyCompletedNCT01526343Phase 2Results posted
• Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial FibrillationCompletedNCT01522651Phase 2Results posted
• Evaluation of the Incidence of Cerebral Lesions Post Pulmonary Vein Ablation Catheter (PVAC)CompletedNCT01520532Not applicableResults posted
• A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial FibrillationCompletedNCT01493557Phase 4Results posted
• Post-Marketing Surveillance of Prazaxa® on the Long-term Use in Patients With Nonvalvular Atrial FibrillationCompletedNCT01491178Results posted
• Diagnostic Device Risk Management of Atrial Fibrillation and Heart FailureCompletedNCT01486316Not applicableResults posted
• Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial FibrillationTerminatedNCT01483183Phase 1Results posted
• GLORIA-AF Registry Program - Second and Third PhasesCompletedNCT01468701Results posted
• Atrial Fibrillation Without Hemodynamic Instability in the Intensive Care UnitCompletedNCT01461733Phase 4Results posted
• Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (STOP AF PAS)CompletedNCT01456949Not applicableResults posted
• HeartLight Ablation in Patients With Paroxysmal Atrial Fibrillation (PAF)CompletedNCT01456000Phase 3Results posted
• Minimally Invasive Surgical Treatment Versus Medical Management for Stroke Patients With Atrial FibrillationCompletedNCT01442181Not applicableResults posted
• GLORIA-AF Registry Program (Phase I)CompletedNCT01428765Results posted
• Rhythm Control - Catheter Ablation With or Without Anti-arrhythmic Drug Control of Maintaining Sinus Rhythm Versus Rate Control With Medical Therapy and/or Atrio-ventricular Junction Ablation and Pacemaker Treatment for Atrial FibrillationCompletedNCT01420393Not applicableResults posted
• Catheter Ablation Versus Medical Treatment of AF in Heart FailureCompletedNCT01411371Not applicableResults posted
• THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial FibrillationCompletedNCT01385202Phase 3Results posted
• Study of Normal Conditions of Use, Dosing, and Safety of Intravenous (IV) Administration of Vernakalant (MK-6621-049)CompletedNCT01370629Results posted
• REVOLUTION (WFCC-133) - Treatment of Paroxysmal Atrial FibrillationCompletedNCT01353586Phase 2Results posted
• Suppression Of Atrial Fibrillation With Ranolazine After Cardiac SurgeryTerminatedNCT01352416Phase 3Results posted
• Ranolazine for the Prevention of Atrial Fibrillation After Electrical CardioversionTerminatedNCT01349491Phase 3Results posted
• TactiCath Contact Force Ablation Catheter Study for Atrial FibrillationCompletedNCT01278953Not applicableResults posted
• Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung CancerTerminatedNCT01259284Phase 2/3Results posted
• Evaluation Of New Onset Postoperative Atrial FibrillationCompletedNCT01247974Not applicableResults posted
• Dual Epicardial Endocardial Persistent Atrial Fibrillation (AF) StudyCompletedNCT01246466Not applicableResults posted
• Evaluate the Pharmacokinetics and Safety of MK-4448 in Participants With Nonvalvular Atrial Fibrillation or Atrial FlutterCompletedNCT01229254Phase 2Results posted
• PETRO Stroke Prevention in Patients With AF by Treatment With Dabigatran, With and Without Aspirin, Compared to WarfarinCompletedNCT01227629Phase 2Results posted
• TOCCATA - Touch+™ for Catheter AblationCompletedNCT01223469Not applicableResults posted
• Oral Steroids Before Pulmonary Vein Isolation to Improve OutcomesCompletedNCT01206452Phase 4Results posted
• ST-segment Elevation as an AF EndophenotypeCompletedNCT01205529Not applicableResults posted
• Effects of Dronedarone on Cardiac Geometry and Function in Patients With Atrial Fibrillation and Left Atrial EnlargementTerminatedNCT01198873Phase 4Results posted
• n-3 Polyunsaturated Fatty Acids (PUFAs) in the Prevention of Atrial FibrillationCompletedNCT01198275Phase 3Results posted
• Post-Market Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (CF-EAS-AC) for the Treatment of Symptomatic Atrial FibrillationCompletedNCT01196923Phase 4Results posted
• Effect of Structural Remodeling on Scar Formation as Assessed by DE-MRI of the Left AtriumCompletedNCT01187914Results posted
• Evaluation of the WATCHMAN Left Atrial Appendage (LAA) Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin TherapyCompletedNCT01182441Phase 3Results posted
• SOAR: Study Observing Antiarrhythmic Remodelling Using LGE-MRICompletedNCT01182376Phase 3Results posted
• Assessing Arrhythmias After Ablation Using Implantable RecordersCompletedNCT01176617Not applicableResults posted
• A Study of the Efficacy and Safety of Vernakalant Hydrochloride (MK-6621) in Patients With Atrial Fibrillation (MK-6621-010 AM4)CompletedNCT01174160Phase 3Results posted
• Left Atrial Distensibility to Predict Left Ventricular Filling Pressure and Prognosis in Patients With Severe Mitral RegurgitationCompletedNCT01172184Results posted
• Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard TherapyTerminatedNCT01151137Phase 3Results posted
• A Dose Response Study of Dabigatran Etexilate(BIBR 1048) in Pharmacodynamics and Safety in Patients With Non-valvular Atrial Fibrillation in Comparison to WarfarinCompletedNCT01136408Phase 2Results posted
• Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent PacemakersTerminatedNCT01135017Phase 4Results posted
• Use of the Hansen Medical System in Patients With Paroxysmal Atrial FibrillationTerminatedNCT01122173Not applicableResults posted
• International Registry on Cardioversion of Atrial Fibrillation (MK-6621-051)CompletedNCT01119716Results posted
• AMPLATZER Cardiac Plug Clinical TrialCompletedNCT01118299Not applicableResults posted
• Vitamin C for Prophylaxis of Post-operative Atrial Fibrillation in On-pump Cardiac Surgery ProceduresCompletedNCT01107730Phase 3Results posted
• Post-Market Randomized Trial: Endoscopically- Guided Ablation vs. Radiofrequency AblationTerminatedNCT01057394Phase 4Results posted
• Irrigated Ablation System Evaluation for Atrial Fibrillation (AF)CompletedNCT01056328Not applicableResults posted
• Guided Radiofrequency Ablation Using the CARTO® 3 and NavX™ Systems for the Treatment of Paroxysmal Atrial FibrillationTerminatedNCT01036724Results posted
• Modified Ablation Guided by Ibutilide Use in Chronic Atrial FibrillationCompletedNCT01014741Not applicableResults posted
• The Dynamics of Human Atrial FibrillationCompletedNCT01008722Results posted
• Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial FibrillationCompletedNCT00971204Phase 2Results posted
• Omega-3 Fatty Acids for Prevention of Post-Operative Atrial FibrillationCompletedNCT00970489Phase 3Results posted
• NAVISTAR® THERMOCOOL® Catheter Post Approval RegistryCompletedNCT00964392Phase 4Results posted
• Clinical Study of the CardioFocus Endoscopic Ablation System for the Treatment of Symptomatic AFCompletedNCT00958165Phase 3Results posted
• Prophylaxis to Reduce Postoperative Atrial Fibrillation in Cardiac SurgeryCompletedNCT00953212Phase 3Results posted
• Selective Complex Fractionated Atrial Electrograms (CFAE) Targeting for Atrial FibrillationCompletedNCT00926783Phase 4Results posted
• Intravenous Cardioversion of Atrial Fibrillation (AF) With AZD1305CompletedNCT00915356Phase 2Results posted
• Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation TrialCompletedNCT00911508Not applicableResults posted
• Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart RhythmCompletedNCT00911300Phase 2Results posted
• Randomized Trial of Interventions to Improve Warfarin AdherenceCompletedNCT00904982Not applicableResults posted
• Surgical Ablation Versus No Surgical Ablation for Patients With Atrial Fibrillation Undergoing Mitral Valve SurgeryCompletedNCT00903370Phase 2Results posted
• Continued Access ProtocolCompletedNCT00889681Not applicableResults posted
• Personalized Warfarin Dosing by Genomics and Computational IntelligenceTerminatedNCT00872079Not applicableResults posted
• AVAI: Atrial Ventricular Arrythmia IncidenceCompletedNCT00832975Results posted
• Late Phase 2 Study of DU-176b in Patients With Non-Valvular Atrial FibrillationCompletedNCT00829933Phase 2Results posted
• Effect of Balloon Cryoablation on Left Atrial FunctionCompletedNCT00821015Not applicableResults posted
• Prothrombin Times Outside the Therapeutic Range in Otherwise Stable PatientsCompletedNCT00814177Phase 2Results posted
• European Carto® XP REgistry for Validating Specialized CFAE SOftwareCompletedNCT00812916Results posted
• Clinical effecT of Heart Failure Management Via Home Monitoring With a Focus on Atrial Fibrillation (effecT)TerminatedNCT00811382Not applicableResults posted
• RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY TrialCompletedNCT00808067Phase 3Results posted
• Corticosteroid Pulse After AblationCompletedNCT00807586Phase 4Results posted
• DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial FibrillationCompletedNCT00806624Phase 2Results posted
• Effects of Fish Oil on Post Ablation ArrhythmiasTerminatedNCT00791089Phase 4Results posted
• The Use of Dual Chamber ICD With Special Programmed Features to Lower the Risk of Inappropriate ShockCompletedNCT00787800Phase 4Results posted
• A Phase 2 Study To Evaluate The Safety Of Apixaban In Atrial FibrillationCompletedNCT00787150Phase 2Results posted
• Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study)CompletedNCT00786474Phase 3Results posted
• Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial FibrillationCompletedNCT00781391Phase 3Results posted
• PV-Isolation With the Cryoballoon Versus RF:a Randomized Controlled Prospective Non-inferiority Trial (FreezeAF)CompletedNCT00774566Phase 4Results posted
• Does Atorvastatin Prevent Post Operative Atrial Fibrillation After Pulmonary Resection: A Randomized Clinical StudyCompletedNCT00756886Not applicableResults posted
• Ablation of the Pulmonary Veins for Paroxysmal AfibCompletedNCT00744874Phase 4Results posted
• Phase 2 Study of the Safety, Tolerability and Pilot Efficacy of Oral Factor Xa Inhibitor Betrixaban Compared to WarfarinCompletedNCT00742859Phase 2Results posted
• Study of HD Mesh Ablation System for Treatment of Paroxysmal Atrial FibrillationTerminatedNCT00741611Phase 3Results posted
• NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation- Treatment Use StudyTerminatedNCT00721149Phase 3Results posted
• Randomized Study of the Use of Warfarin During Pacemaker or ICD Implantation in Patients Requiring Long Term AnticoagulationCompletedNCT00721136Not applicableResults posted
• Surgical or Catheter Ablation of Lone Atrial Fibrillation (AF) PatientsTerminatedNCT00703157Not applicableResults posted
• Prevention of Stroke and Systemic Embolic Events in Patients With Atrial FibrillationCompletedNCT00684307Phase 2Results posted
• Long-term Safety in Atrial Fibrillation PatientsCompletedNCT00645853Phase 2Results posted
• Explorative Study of AZD1305 in Atrial Fibrillation PatientsCompletedNCT00643448Phase 2Results posted
• Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA)CompletedNCT00623779Phase 2Results posted
• AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot StudyTerminatedNCT00589303Phase 3Results posted

← Atrial Fibrillation overview